Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
AstraZeneca
Tag: AstraZeneca
AstraZeneca (LON:AZN) had its Sell rating reiterated by UBS Group
ME Staff
-
April 23, 2019
0
AstraZeneca (LON:AZN) had its Buy rating reiterated by Deutsche Bank with...
ME Staff
-
April 8, 2019
0
AstraZeneca (LON:AZN) price target raised to GBX 6,400 by Liberum Capital
ME Staff
-
April 5, 2019
0
AstraZeneca (NYSE:AZN) gets downgraded to Sell by UBS Group
ME Staff
-
April 2, 2019
0
AstraZeneca (LON:AZN) had its Hold rating reiterated by Jefferies Financial Group...
ME Staff
-
March 29, 2019
0
AstraZeneca (LON:AZN) had its Sell rating reiterated by Goldman Sachs Group
ME Staff
-
March 18, 2019
0
AstraZeneca (LON:AZN) had its Hold rating reiterated by Jefferies Financial Group
ME Staff
-
March 14, 2019
0
AstraZeneca (LON:AZN) price target raised to GBX 5,000 by Goldman Sachs...
ME Staff
-
March 12, 2019
0
AstraZeneca (LON:AZN) had its Overweight rating reiterated by Barclays
ME Staff
-
March 11, 2019
0
AstraZeneca (LON:AZN) price target set to GBX 4,080 by Goldman Sachs...
ME Staff
-
February 26, 2019
0
1
2
3
4
Page 1 of 4
/* */
// AST – IMS - [MarketExclusive_ROS]